PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Philippe Froguel Selected Research
Obesity
10/2008
Response to the letter to the editor: "HIF-1{alpha} protein rather than mRNA as a marker of hypoxia in adipose tissue in obesity," by Trayhurn et al.
07/2008
Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations.
12/2007
Silencing of OB-RGRP in mouse hypothalamic arcuate nucleus increases leptin receptor signaling and prevents diet-induced obesity.
11/2007
Genetic study of the melanin-concentrating hormone receptor 2 in childhood and adulthood severe obesity.
08/2007
Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene.
03/2007
No contribution of angiotensin-converting enzyme (ACE) gene variants to severe obesity: a model for comprehensive case/control and quantitative cladistic analysis of ACE in human diseases.
06/2006
Genetic polymorphisms and weight loss in obesity: a randomised trial of hypo-energetic high- versus low-fat diets.
02/2006
ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity.
12/2005
ACDC/adiponectin and PPAR-gamma gene polymorphisms: implications for features of obesity.
10/2005
Association of melanin-concentrating hormone receptor 1 5' polymorphism with early-onset extreme obesity.
04/2005
Is glutamate decarboxylase 2 (GAD2) a genetic link between low birth weight and subsequent development of obesity in children?
03/2005
Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population.
09/2004
Polymorphisms in the amino acid transporter solute carrier family 6 (neurotransmitter transporter) member 14 gene contribute to polygenic obesity in French Caucasians.
Articles by Research Topic
Disease
13
Obesity
10/2008 - 09/2004
3
Insulin Resistance
07/2004 - 07/2002
2
Syndrome
01/2006 - 04/2004
1
Anoxia (Hypoxia)
10/2008
1
Type 2 Diabetes Mellitus (MODY)
03/2008
1
Weight Loss (Weight Reduction)
06/2006
1
Hyperglycemia
04/2004
1
Overweight
03/2004
1
Atherosclerosis (Atheroma)
01/2003
Drug/Important Bio-Agent (IBA)
6
Adiponectin
IBA
02/2006 - 07/2002
3
PPAR gamma
IBA
03/2008 - 03/2005
2
melanin-concentrating hormone receptor
IBA
11/2007 - 10/2005
1
Messenger RNA (mRNA)
IBA
10/2008
1
Endocannabinoids (Endocannabinoid)
IBA
07/2008
1
Leptin Receptors
IBA
12/2007
1
Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)
IBA
08/2007
1
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
IBA
03/2007
1
glutamate decarboxylase 2
IBA
04/2005
1
Amino Acid Transport Systems (Amino Acid Transporter)
IBA
09/2004
1
Neurotransmitter Agents (Neurotransmitter)
IBA
09/2004
1
Nonsense Codon (Nonsense Mutation)
IBA
07/2004
1
Insulin (Novolin)
FDA Link
03/2004
1
Apolipoproteins E (ApoE)
IBA
01/2003
Therapy/Procedure
1
Fat-Restricted Diet (Diet, Fat Restricted)
06/2006